<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neural Dev</journal-id>
<journal-id journal-id-type="iso-abbrev">Neural Dev</journal-id>
<journal-title-group>
<journal-title>Neural Development</journal-title>
</journal-title-group>
<issn pub-type="epub">1749-8104</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30217225</article-id>
<article-id pub-id-type="pmc">6138899</article-id>
<article-id pub-id-type="publisher-id">119</article-id>
<article-id pub-id-type="doi">10.1186/s13064-018-0119-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genomic analysis of transcriptional networks directing progression of cell states during MGE development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0809-0656</contrib-id>
<name>
<surname>Sandberg</surname>
<given-names>Magnus</given-names>
</name>
<address>
<email>bmagnussandberg@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taher</surname>
<given-names>Leila</given-names>
</name>
<address>
<email>leila.taher@fau.de</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Jianxin</given-names>
</name>
<address>
<email>Jianxin.Hu@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Black</surname>
<given-names>Brian L.</given-names>
</name>
<address>
<email>brian.black@ucsf.edu</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nord</surname>
<given-names>Alex S.</given-names>
</name>
<address>
<email>asnord@ucdavis.edu</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rubenstein</surname>
<given-names>John L. R.</given-names>
</name>
<address>
<email>john.rubenstein@ucsf.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution>Department of Psychiatry, UCSF Weill Institute for Neurosciences, </institution><institution>University of California, </institution></institution-wrap>San Francisco, San Francisco, CA 94143 USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2107 3311</institution-id><institution-id institution-id-type="GRID">grid.5330.5</institution-id><institution>Division of Bioinformatics, Department of Biology, </institution><institution>Friedrich-Alexander Universität Erlangen-Nürnberg, </institution></institution-wrap>91054 Erlangen, Germany </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2297 6811</institution-id><institution-id institution-id-type="GRID">grid.266102.1</institution-id><institution>Cardiovascular Research Institute, </institution><institution>University of California, </institution></institution-wrap>San Francisco, CA 94143 USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9684</institution-id><institution-id institution-id-type="GRID">grid.27860.3b</institution-id><institution>Department of Psychiatry and Behavioral Sciences, </institution><institution>University of California, </institution></institution-wrap>Davis, Davis, CA 95817 USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 9684</institution-id><institution-id institution-id-type="GRID">grid.27860.3b</institution-id><institution>Department of Neurobiology, Physiology, and Behavior, </institution><institution>University of California, </institution></institution-wrap>Davis, Davis, CA 95616 USA </aff>
<aff id="Aff6"><label>6</label>Present address: Biogen, Cambridge, 02142 MA USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>14</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>14</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>13</volume>
<elocation-id>21</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Homeodomain (HD) transcription factor (TF) NKX2–1 critical for the regional specification of the medial ganglionic eminence (MGE) as well as promoting the GABAergic and cholinergic neuron fates via the induction of TFs such as LHX6 and LHX8. NKX2–1 defines MGE regional identity in large part through transcriptional repression, while specification and maturation of GABAergic and cholinergic fates is mediated in part by transcriptional activation via TFs such as LHX6 and LHX8. Here we analyze the signaling and TF pathways, downstream of NKX2–1, required for GABAergic and cholinergic neuron fate maturation.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">Differential ChIP-seq analysis was used to identify regulatory elements (REs) where chromatin state was sensitive to change in the <italic>Nkx2–1</italic>cKO MGE at embryonic day (E) 13.5. TF motifs in the REs were identified using RSAT. CRISPR-mediated genome editing was used to generate enhancer knockouts. Differential gene expression in these knockouts was analyzed through RT-qPCR and in situ hybridization. Functional analysis of motifs within <italic>hs623</italic> was analyzed via site directed mutagenesis and reporter assays in primary MGE cultures.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">We identified 4782 activating REs (aREs) and 6391 repressing REs (rREs) in the <italic>Nkx2–1</italic> conditional knockout (<italic>Nkx2–1</italic>cKO) MGE. aREs are associated with basic-Helix-Loop-Helix (bHLH) TFs. Deletion of <italic>hs623</italic>, an intragenic <italic>Tcf12</italic> aRE, caused a reduction of <italic>Tcf12</italic> expression in the sub-ventricular zone (SVZ) and mantle zone (MZ) of the MGE. Mutation of LHX, SOX and octamers, within <italic>hs623</italic>, caused a reduction of <italic>hs623</italic> activity in MGE primary cultures.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4"><italic>Tcf12</italic> expression in the SVZ of the MGE is mediated through aRE <italic>hs623</italic>. The activity of <italic>hs623</italic> is dependent on LHX6, SOX and octamers. Thus, maintaining the expression of <italic>Tcf12</italic> in the SVZ involves on TF pathways parallel and genetically downstream of NKX2–1.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s13064-018-0119-4) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>TCF12</kwd>
<kwd>SOX</kwd>
<kwd>OCT</kwd>
<kwd>LHX</kwd>
<kwd>MEIS</kwd>
<kwd>Medial ganglionic eminence</kwd>
<kwd>CRISPR engineering</kwd>
<kwd>Transcriptional network</kwd>
<kwd>Neurogenesis</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000025</institution-id>
<institution>National Institute of Mental Health</institution>
</institution-wrap>
</funding-source>
<award-id>MH081880</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id>
<institution>Vetenskapsrådet</institution>
</institution-wrap>
</funding-source>
<award-id>2011-38865-83000-30</award-id>
<principal-award-recipient>
<name>
<surname>Sandberg</surname>
<given-names>Magnus</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003748</institution-id>
<institution>Svenska Sällskapet för Medicinsk Forskning</institution>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id>
<institution>National Institutes of Health</institution>
</institution-wrap>
</funding-source>
<award-id>HL136182</award-id>
<award-id>HL064658</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par20">Transcription factors (TFs) direct cell fate determination and differentiation through binding to a genomic network consisting of regulatory elements (REs) such as promoters and enhancers. By analyzing epigenetic modifications and transcriptional changes in TF knockouts, we have started to uncover the genomic networks and molecular mechanisms that direct brain development [<xref ref-type="bibr" rid="CR1">1</xref>]. In-depth understanding of the genetically encoded wiring of the brain is important as perturbation of transcription pathways is implicated in disorders such as autism and intellectual disability [<xref ref-type="bibr" rid="CR2">2</xref>]. Distantly acting REs have been identified based on conservation and activity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Their spatial activity and dynamic genomic contacts can be predicted using a combination of TF binding profiling, genome-wide 3D chromosome organization mapping and CRISPR/Cas9 editing [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR10">10</xref>].</p>
<p id="Par21">Mouse genetic experiments have elucidated the functions of many TFs in the development of the subpallial telencephalon [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. These studies show that the HD protein NKX2–1 is required for regional specification of the MGE by repressing alternative identities, as well as promoting GABAergic and cholinergic cell fates via the induction of TFs such as LHX6 and LHX8 [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. By integrating genomic data with mouse genetics, we confirmed the repressive function of NKX2–1, however its role in transcriptional activation remains unclear. Moreover, additional data suggests that genes genetically downstream of NKX2–1, such as LHX6 and LHX8, are responsible for the loss of gene expression observed in the <italic>Nkx2–1</italic>cKO [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Altogether, the genetic program and molecular mechanisms responsible for promoting GABAergic and cholinergic neuron phenotypes, downstream of NKX2–1 remains largely unexplored.</p>
<p id="Par22">To investigate the signaling pathways of MGE development downstream of NKX2–1, we extended our earlier analysis of the genomic network directing MGE development that is altered in the <italic>Nkx2–1</italic> mutant. First we evaluated all loci that showed an epigenetic change, independent of NKX2–1 binding. Via an epigenomic analysis of the NKX2–1 mutant MGE we characterized a large set REs that are implicated in mediating transcriptional repression and activation. Using a combination of genomics, de novo <italic>motif</italic> analysis, CRISPR engineering and primary culture assays we characterize REs and TFs central to patterning of the subpallial telencephalon and promoting MGE characteristics. Gene ontology (GO) analysis showed an enriched association of REs activating transcription (aREs) with E-box binding basic-Helix-Loop-Helix (bHLH) TFs. Using CRISPR engineering we deleted <italic>hs623</italic>, an intronic aRE of the <italic>Tcf12</italic> gene which encodes a bHLH TF. Deletion of <italic>hs623</italic> reduced <italic>Tcf12</italic> expression in the MGE. De novo motif analysis combined with TF motif mutations, showed that OCT/POU and SOX motifs are required for <italic>hs623</italic>’s ability to promote transcription in the MGE.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Mice</title>
<p id="Par23">The <italic>Nkx2–1</italic>cKO was earlier described in Sandberg et al. 2016 [<xref ref-type="bibr" rid="CR18">18</xref>] and generated using mice strains previously reported: <italic>Nkx2–1f/f</italic> [<xref ref-type="bibr" rid="CR20">20</xref>], <italic>Olig2-tva</italic>-Cre [<xref ref-type="bibr" rid="CR21">21</xref>] and <italic>AI14</italic> Cre-reporter [<xref ref-type="bibr" rid="CR22">22</xref>]. All experiments with animals complied with federal and institutional guidelines and were reviewed and approved by the UCSF Institutional Animal Care and Use Committee.</p>
</sec>
<sec id="Sec4">
<title>Generation of <italic>hs623</italic> deletion</title>
<p id="Par24">The <italic>hs623</italic><sup><italic>Tm1</italic></sup> allele was generated by CRISPR-mediated genome editing, using established methods [<xref ref-type="bibr" rid="CR23">23</xref>]. Guide RNAs sgRNA-<italic>hs623</italic>–1, 5′-GTTTAGTTTTGCTCATACCA(TGG)-3′ and sgRNA-<italic>hs623</italic>–2, 5′-ATGGTTTCTGTGATCGTAAT(TGG)-3′ (protospacer-adjacent motif [PAM] sequence indicated in parentheses) were transcribed in vitro using the MEGAshortscript T7 kit (Life Technologies, AM1354) and subsequently purified using the MEGAclear kit (Life Technologies, AM1908). The two guide RNAs were designed to delete a 737 bp intronic region within <italic>Tcf12</italic> [mm9; chr9:71822812–71823548]. The purified sgRNAs were co-injected into the cytoplasm of fertilized mouse oocytes with in vitro transcribed Cas9 mRNA using standard transgenic procedures as previously described [<xref ref-type="bibr" rid="CR24">24</xref>]. F0 transgenic founders were identified by PCR screening using <italic>hs623</italic>-KO-F, 5′- GTCATTGTTGCTGTTGGCCT -3′ and <italic>hs623</italic>-KO-R, 5′- CCACCTCACACTAGATTAAGATACA -3′ to identify the <italic>hs623</italic> null alleles (KO = 250 bp, WT = 1008 bp) and <italic>hs623</italic>-WT-F, 5’-GTGGCTGATGATGTGCTCTGA -3′ and <italic>hs623</italic>-WT-R, 5’-CTCCATCAGGTTCTTGCCCC-3′ to identify the <italic>hs623</italic>-WT allele (462 bp). Four independent F0 founders were each outcrossed to wild type mice, and F1 offspring were used for subsequent <italic>hs623</italic><sup><italic>Tm1</italic></sup> intercrosses to generate <italic>hs623</italic>-null mice. The hs623 mutant strain (CD1-<italic>Tcf12</italic><sup><italic>em1Jlr</italic></sup>/Mmucd) is available at MMRC (<ext-link ext-link-type="uri" xlink:href="http://www.mmrrc.org/">www.mmrrc.org/</ext-link>) with the number RRID: MMRRC_044027-UCD.</p>
</sec>
<sec id="Sec5">
<title>Histology</title>
<p id="Par25">Immunofluorescence was performed on 16 μm cryosection as previously described [<xref ref-type="bibr" rid="CR25">25</xref>]. In situ hybridization was performed as previously described [<xref ref-type="bibr" rid="CR26">26</xref>]. The following primers were used generate the templates used for the in situ probes: Tcf12_F, TCTCGAATGGAAGACCGC; Tcf12_R, CTCCCTCCTGCCAGGTTT.</p>
</sec>
<sec id="Sec6">
<title>Dissection of embryos</title>
<p id="Par27">RT-qPCR and primary culture experiments were performed on E13.5 micro-dissected MGE. All MGE dissections were performed as follows; the dorsal boundary was defined by the sulcus separating lateral ganglionic eminence (LGE) and MGE. The caudal end of the sulcus defined the caudal boundary. Septum was removed.</p>
</sec>
<sec id="Sec7">
<title>Gene expression analysis in <italic>hs623</italic>KO</title>
<p id="Par28">To assay differential gene expression in the <italic>hs623</italic>KO RNA was purified using RNEasy Mini (Qiagen) and cDNA was generated using Superscript III® First-Strand Synthesis System for RT-PCR (Invitrogen). RT-qPCR analysis was performed on a 7900HT Fast Real-Time PCR System (Applied Biosystems) using SYBR GreenER qPCR SuperMix (Invitrogen, Cat. No. 11760–100). Unpaired t-test was used to test significance in gene expression between <italic>hs623</italic>WT and <italic>hs623</italic>KO using SDHA as internal control [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>].</p>
<p id="Par29">Sequences of RT-qPCR primers used:<list list-type="bullet"><list-item><p id="Par30">SDHA-F, GCTCCTGCCTCTGTGGTTGA</p></list-item><list-item><p id="Par31">SDHA-R, AGCAACACCGATGAGCCTG</p></list-item><list-item><p id="Par32">Mns1_ctrl_1F, CTGCTGCTCCGGAAGACG</p></list-item><list-item><p id="Par33">Mns1_ctrl_1R, TTTTGGTCGCCATCTCGGTT</p></list-item><list-item><p id="Par34">Myzap_ctrl_2F, TCGAAAGGAAAGATCAGCCTCC</p></list-item><list-item><p id="Par35">Myzap_ctrl_2R, TCTGATCTTCGCACCACACC</p></list-item><list-item><p id="Par36">Zfp280d_ctrl_1F, CCCCAGCTCTCATTCAAGAGG</p></list-item><list-item><p id="Par37">Zfp280d_ctrl_1R, TTCAGGCAGCGTTGACTTGT</p></list-item><list-item><p id="Par38">TCF12_v1/2-F2, GCTTGTCCCCAACACCTTTC</p></list-item><list-item><p id="Par39">TCF12_v1/2-R2, TGACAGCCTGAGAGTCCAGA</p></list-item><list-item><p id="Par40">TCF12_v1/3-F4, TACCAGTCAGTGGCCCAGAG</p></list-item><list-item><p id="Par41">TCF12_v1/3-R4, AATGCTCGTGAAGTTGCTGC</p></list-item><list-item><p id="Par42">TCF12_v1/3-F5, TCCCTGGAATGGGCAACAAT</p></list-item><list-item><p id="Par43">TCF12_v1/3-R5, TCACGGTTGAAATCGTCAGA</p></list-item></list></p>
</sec>
<sec id="Sec8">
<title>Site-directed mutagenesis of TF binding motifs in <italic>hs623</italic></title>
<p id="Par44">To study the requirement TF motifs for <italic>hs623</italic> activity LHX6, SOX and octamers were mutated in pCR-Blunt II-TOPO, sequence verified and sub-cloned into a pGL4.23-Luciferase reporter with a minimal β-globin-promoter using BglII and XhoI [<xref ref-type="bibr" rid="CR18">18</xref>]. Following primers were used to generate the different <italic>hs623</italic> luciferase reporters:<list list-type="bullet"><list-item><p id="Par45"><italic>hs623</italic>-mut-site#1-R, cgttgctgacaaggctgttttttacagaaattgatgctgagttc</p></list-item><list-item><p id="Par46"><italic>hs623</italic>-mut-site#1-F, agccttgtcagcaacgtgattattcaaac</p></list-item><list-item><p id="Par47"><italic>hs623</italic>-mut-site#2-F, gatgtgctctgatatgaaaaaagtcattaggtagaatgaatag</p></list-item><list-item><p id="Par48"><italic>hs623</italic>-mut-site#3-F, gatgtgctctgatatgtaattagaaaaaaggtagaatgaatag</p></list-item><list-item><p id="Par49"><italic>hs623</italic>-mut-site#2 and 3-F, gatgtgctctgatatgaaaaaagaaaaaaggtagaatgaatag</p></list-item><list-item><p id="Par50"><italic>hs623</italic>-mut-site#2 and/or 3-R, atatcagagcacatcatcagccacattc</p></list-item><list-item><p id="Par51"><italic>hs623</italic>-mut-site#4-F, gattattcaaacaactcttttttttgttaatgagg</p></list-item><list-item><p id="Par52"><italic>hs623</italic>-mut-site#4-R, gagttgtttgaataatcacgttgctgac</p></list-item><list-item><p id="Par53"><italic>hs623</italic>-mut-site#5-F, ctcatgcaaatgaaaaagaggccttatttgc</p></list-item><list-item><p id="Par54"><italic>hs623</italic>-mut-site#5-R, atttgcatgagttgtttgaataatc</p></list-item><list-item><p id="Par55"><italic>hs623</italic>-mut-site#4 and 5-F, caaacaactcttttttttgaaaaagaggccttatttgc</p></list-item><list-item><p id="Par56"><italic>hs623</italic>-mut-site#4 and 5-R, use “<italic>hs623</italic>-mut-site#4-R” for PCR</p></list-item><list-item><p id="Par57"><italic>hs623</italic>-mut-site#6-F, gttaatgaggccttaaaaaaatatttattttttcc</p></list-item><list-item><p id="Par58"><italic>hs623</italic>-mut-site#6-R, ggcctcattaacatttgcatgagttgtttg</p></list-item><list-item><p id="Par59"><italic>hs623</italic>-mut-site#4 and 6-F, caactcttttttttgttaatgaggccttaaaaaaatatttattttttcc</p></list-item><list-item><p id="Par60"><italic>hs623</italic>-mut-site#4 and 6-R, cattaacaaaaaaaagagttgtttgaataatcac</p></list-item><list-item><p id="Par61"><italic>hs623</italic>-mut-site#4,5 and 6-F, caactcttttttttgaaaaagaggccttaaaaaaatatttattttttcc</p></list-item><list-item><p id="Par62"><italic>hs623</italic>-mut-site#4, 5 and 6-R, ggcctctttttcaaaaaaaagagttgtttgaataatc</p></list-item><list-item><p id="Par63"><italic>hs623</italic>-mut-site#7-F, gcaacgtgattattcccccccctcatgcaaatg</p></list-item><list-item><p id="Par64"><italic>hs623</italic>-mut-site#7-R, gaataatcacgttgctgacaagg</p></list-item><list-item><p id="Par65"><italic>hs623</italic>-mut-site#4 and 7-F, gtgattattcccccccctcttttttttgttaatgagg</p></list-item><list-item><p id="Par66"><italic>hs623</italic>-mut-site#4 and 7-R, use <italic>hs623</italic>-mut-site#7-R</p></list-item></list></p>
</sec>
<sec id="Sec9">
<title>Analysis of <italic>hs623</italic> activity in MGE primary MGE cultures</title>
<p id="Par67">MGE tissue was dissected from E13.5 embryos, triturated and plated onto 24-well plates (1 embryo/2wells). Primary cultures were transfected with a total of 500 ng DNA using Lipofectamin 2000 (Thermo Fisher) and cultured in Neurobasal Medium (Thermo Fisher) supplemented with 0.5% Glucose, GlutaMAX (Thermo Fisher Scientific) and B27 (Thermo Fisher Scientific). Luciferase assays were performed 48 h after transfection using Dual Luciferase Reporter Assay System (Promega). Unpaired t-test was used to test significance between the variants of <italic>hs623</italic>.</p>
</sec>
<sec id="Sec10">
<title>ChIP-Seq computational analysis</title>
<p id="Par68">Differential ChIP-seq analysis was performed as described in Sandberg et al. 2016 [<xref ref-type="bibr" rid="CR18">18</xref>]. After differential H3K4me1, H3K27ac and H3K27me3 analysis we merged overlapping sites. Only merged sites that were enriched in H3K4me1 relative to the input datasets and for which the difference in enrichment between <italic>Nkx2–1</italic> WT and cKO was not significant (for at least one of the sites among the merged sites) were further considered. Of those, merged sites overlapping with blacklisted genomic regions (<ext-link ext-link-type="uri" xlink:href="http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/mm9-mouse/mm9-blacklist.bed.gz">http://mitra.stanford.edu/kundaje/akundaje/release/blacklists/mm9-mouse/mm9-blacklist.bed.gz</ext-link>) and RepeatMasker annotation (http://hgdownload.cse.ucsc.edu/goldenPath/mm9/database/chr*_rmsk.txt.gz) as well as those exceeding 5000 bp were excluded. We defined aREs based on the following two criteria; 1) more H3K27ac (WT) and no increase in H3K27me3 (WT), H3K27ac (<italic>Nkx2–1</italic>cKO) and H3K4me1 (<italic>Nkx2–1</italic>cKO), 2) more H3K27me3 (<italic>Nkx2–1</italic>cKO) and no increase in H3K27ac (<italic>Nkx2–1</italic>cKO), H3K4me1 (<italic>Nkx2–1</italic>cKO) and H3K27me3 (WT). We defined rREs based on the following two criteria; 1) more H3K27ac (<italic>Nkx2–1cKO)</italic> and no increase in H3K27me3 (<italic>Nkx2–1</italic>cKO<italic>)</italic>, H3K27ac (WT) and H3K4me1 (WT), 2) more H3K27me3 (<italic>WT)</italic> and no increase in H3K27ac (WT), H3K4me1 (<italic>WT)</italic> and H3K27me3 (<italic>Nkx2–1</italic>cKO<italic>)</italic>.</p>
</sec>
<sec id="Sec11">
<title>In vivo analysis of aREs and rREs</title>
<p id="Par69">To assess the in vivo activity of aREs and rREs we used the data published in the VISTA Enhancer Browser (<ext-link ext-link-type="uri" xlink:href="https://enhancer.lbl.gov/">https://enhancer.lbl.gov/</ext-link>) [<xref ref-type="bibr" rid="CR7">7</xref>]. All aREs and rREs, overlapping with regions tested in the VISTA Enhancer Browser were scored based on their in vivo activity in cortex, MGE and LGE. For the MGE active elements, we also scored their activity in the ventricular zone (VZ), SVZ and MZ.</p>
</sec>
<sec id="Sec12">
<title>De novo motif analysis</title>
<p id="Par70">Motif analysis was performed using RSAT [<xref ref-type="bibr" rid="CR29">29</xref>], identifying overrepresentation and positional bias of words (6 to 7 nucleotides) in the aREs and rREs using an automated Markov model adapted after the analyzed sequence length. Differential analysis of aREs (rREs as control sequence) and rREs (aREs as control sequence) was also performed to identify overrepresented words in the peak sequence.</p>
</sec>
</sec>
<sec id="Sec13">
<title>Results</title>
<sec id="Sec14">
<title>Identification of the genomic regulatory network directing MGE identity</title>
<p id="Par71">We have previously shown that the combined binding of NKX2–1 and LHX6 is a predictive indicator of REs that mediate transcriptional activation in the subventricular (SVZ) and mantle zone (MZ) of the MGE in the developing subpallial telencephalon [<xref ref-type="bibr" rid="CR18">18</xref>]. There is evidence that NKX2–1 generally acts as a repressor in MGE progenitors (in the ventricular zone [VZ]), whereas LHX6, and potentially other TFs and signaling pathways, some of which are genetically downstream of NKX2–1, are important for activating transcription in the SVZ and MZ of the MGE [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. By studying aREs, we aimed to further explore the molecular mechanisms underlying the transcriptional network directing differentiation of the secondary progenitors in the SVZ. One important difference between this study and our earlier study [<xref ref-type="bibr" rid="CR18">18</xref>] is that here we look at all aREs and rREs, independent of NKX2–1 binding.</p>
<p id="Par72">First we identified aREs and rREs by assessing the genome-wide changes of the two histone marks H3K27ac and H3K27me3 at H3K4me1 positive REs comparing the WT and <italic>Nkx2–1</italic>cKO MGE [<xref ref-type="bibr" rid="CR18">18</xref>]. We defined aREs based on the following two criteria; 1) reduced H3K27ac and, 2) increased H3K27me3 in the <italic>Nkx2–1</italic>cKO. We defined rREs based on the following two criteria; 1) increased H3K27ac and, 2) reduced H3K27me3 in the <italic>Nkx2–1</italic>cKO (see Methods).</p>
<p id="Par73">Based on these criteria we identified 4782 aREs and 6391 rREs in the <italic>Nkx2–1</italic>cKO. See Additional file <xref ref-type="media" rid="MOESM1">1</xref> for a complete list of aREs and rREs. To analyze the in vivo activity patterns of the aREs and rREs we examined transgenic enhancer activity patterns of E11.5 forebrain enhancer activity patterns available in the VISTA database (see VISTA data base; <ext-link ext-link-type="uri" xlink:href="https://enhancer.lbl.gov">https://enhancer.lbl.gov</ext-link>/) [<xref ref-type="bibr" rid="CR7">7</xref>]. The activities of rREs were highest in cortex (62% [13 of 21]) and LGE and dorsal MGE (52% [11 of 21]) and lowest in the ventral MGE (24% [5 of 21])(Fig. <xref ref-type="fig" rid="Fig1">1a</xref> and <xref ref-type="fig" rid="Fig1">b</xref> [hs848, hs1172 and hs1187]). In contrast, aREs have the highest activities in the MGE (53% [17 of 32]) when compared to their activities in the LGE (50% [16 of 32]) and cortex (41% [13 of 32]) (Fig. <xref ref-type="fig" rid="Fig1">1a</xref> and <xref ref-type="fig" rid="Fig1">b</xref> [hs676, hs957 and hs1041]). We also found a higher activity of MGE positive aREs in the SVZ (71% [12 of 17]) and MZ (94% [16 of 17]) compared to the VZ (18% [3 of 17]), consistent with our previous results for NKX2–1 bound aREs and rREs (Fig. <xref ref-type="fig" rid="Fig1">1b</xref> and <xref ref-type="fig" rid="Fig1">c</xref>) [<xref ref-type="bibr" rid="CR18">18</xref>]. See Additional file <xref ref-type="media" rid="MOESM1">1</xref> for a full list of aREs and rREs VISTA transgenics.<fig id="Fig1"><label>Fig. 1</label><caption><p>Characterization of aREs and rREs in E13.5 MGE. <bold>a</bold> Proportion of aREs and rREs active in MGE, LGE and cortex. <bold>b</bold> Sections of transgenic embryos (from the VISTA browser) showing in vivo activity of rREs (hs848, hs1172 and hs1187) and aREs (hs676, hs957 and hs1041) at E11.5. <bold>c</bold> VZ, SVZ, and MZ activity of aREs in the MGE at E11.5. Chi-square test was used to test significance between the groups: *<italic>p</italic> &lt; 0.05. <bold>d</bold> and <bold>e</bold> Manually curated list of de novo motifs and potential TF recognizing the motifs in rREs and aREs. <bold>f</bold> Enriched gene ontology annotations of putative aRE target genes</p></caption><graphic id="MO1" xlink:href="13064_2018_119_Fig1_HTML"></graphic></fig></p>
<p id="Par74">To identify TFs motifs enriched in the aRE and rREs we performed a de novo motif discovery using RSAT [<xref ref-type="bibr" rid="CR29">29</xref>]. This analysis showed a number of motifs enriched in both aREs and rREs such as SOX motifs, homedomain binding motifs (HOX and POU6f2) and motifs recognized by zinc finger TFs (e.g. SP1 and ZNF384) (Fig. <xref ref-type="fig" rid="Fig1">1d</xref> and <xref ref-type="fig" rid="Fig1">e</xref>). Additional analysis identifying motifs differentially enriched between aREs and rREs showed that aREs have a high frequency of E-boxes (Fig. <xref ref-type="fig" rid="Fig1">1e</xref>). Interestingly, we found that rREs are enriched in motifs consistent with the binding site of the TF MEIS2 (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>). The <italic>Meis2</italic> gene is repressed by NKX2–1, and in turn, its RNA is strongly up-regulated in the MGE of the <italic>Nkx2–1</italic>cKO [<xref ref-type="bibr" rid="CR18">18</xref>]. These data suggest that <italic>Meis2</italic> is central to activating a genomic network promoting LGE and caudal ganglionic eminence (CGE) characters (through rREs) in the <italic>Nkx2–1</italic>cKO MGE.</p>
<p id="Par75">We then examined enrichment of annotation terms among the aREs and rREs candidate target genes using GREAT [<xref ref-type="bibr" rid="CR31">31</xref>]. Top-ranked GO terms for rREs target genes were associated with WNT signaling (beta-catenin binding and PDZ domain binding), transcriptional regulation (such as RNA polymerase II transcription co-activator activity), and enhancer sequence-specific DNA binding (Fig. <xref ref-type="fig" rid="Fig1">1f</xref>). Looking specifically at the associated genes for the rREs containing MEIS2 binding motifs we found several genes (<italic>Isl1, Ebf1, Tle4, Zfp503, Efnb1</italic> and <italic>Efnb2</italic>) with higher expression in the LGE and CGE than the MGE. These findings support the hypothesis that MEIS2 directs LGE and CGE identities. The top-ranked GO terms for aREs target genes were associated with phosphatase activity, E-box binding proteins, L-glutamate transmembrane transporter activity and transmembrane-ephrin receptor activity [<xref ref-type="bibr" rid="CR31">31</xref>] (Fig. <xref ref-type="fig" rid="Fig1">1f</xref>). Two E-box binding TFs, <italic>Tcf4</italic> and <italic>Tcf12</italic>, which are in the region of a large number of aREs, have reduced MGE SVZ and MZ expression in the <italic>Nkx2–1</italic>cKO [<xref ref-type="bibr" rid="CR18">18</xref>]. In combination with the high frequency of E-boxes in aREs, our data suggests that <italic>Tcf4</italic> and <italic>Tcf12</italic> are components of the genomic network regulating gene expression in secondary progenitors of the MGE that are genetically downstream of NKX2–1.</p>
</sec>
<sec id="Sec15">
<title>In vivo characterization of <italic>hs623</italic> in the MGE of the forebrain</title>
<p id="Par76">To learn more about the <italic>Tcf12</italic> expression and the transcriptional pathways integrated in the aRE network downstream of NKX2–1, we examined aRE <italic>hs623</italic>, a highly evolutionarily conserved 914 base pair (bp) sequence that is in an intron of the <italic>Tcf12</italic> locus (Fig. <xref ref-type="fig" rid="Fig2">2a</xref> and <xref ref-type="fig" rid="Fig2">b</xref>). A previous transgenic study show that <italic>hs623</italic> drives <italic>LacZ</italic> expression at E11.5 [<xref ref-type="bibr" rid="CR32">32</xref>]. The <italic>hs623</italic> transgene is active in the forebrain, hindbrain and the spinal cord (Fig. <xref ref-type="fig" rid="Fig2">2c-e</xref>, Additional file <xref ref-type="media" rid="MOESM2">2</xref>). A coronal section through the telencephalon shows that <italic>hs623</italic> activity is restricted to the SVZ and MZ of the MGE, and perhaps labels cell tangentially migrating into the LGE (Fig. <xref ref-type="fig" rid="Fig2">2e</xref>). This pattern of activity is supported by histone ChIP-seq analysis of the MGE showing that this locus has histone modifications that are characteristic of active enhancer elements (Fig. <xref ref-type="fig" rid="Fig2">2a</xref> [H3K4me1+ and H3K27ac+] and 2B). Of note, ChIP-seq analysis of the MGE <italic>Nkx2–1</italic>cKO shows reduced H3K27ac, providing evidence that the activity of the locus is dependent on the activity of the NKX2–1 and/or its target TFs, as reported earlier (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>) [<xref ref-type="bibr" rid="CR18">18</xref>].<fig id="Fig2"><label>Fig. 2</label><caption><p>Deletion of <italic>cis</italic>-regulatory element <italic>hs623</italic> in vivo. <bold>a</bold> Genomic region of the <italic>Tcf12</italic> locus with the ChIP-seq datasets and genomic features shown; NKX2–1 ChIP-seq, LHX6 ChIP-seq, H3K4me3, H3K4me1, H3K27ac, H3K27me3, UCSC genes and mammalian conservation. Histone 3 modifications in MGE at E13.5. <italic>Hs623</italic> region framed and highlighted in blue. <bold>b</bold> Higher resolution view of the <italic>hs623</italic> region with the same ChIP-seq datasets as in Fig. 2a. Called NKX2–1 &amp; LHX6 binding region, VISTA regions, deleted <italic>hs623</italic> region (yellow) and NKX2–1, LHX6 and OCT consensus motifs labeled at the top of the browser. <bold>c</bold>-<bold>g</bold> VISTA database transgenic embryos showing in vivo activity of <italic>hs623</italic> and <italic>hs357</italic> at E11.5. <bold>h</bold> Schematic description of the generated <italic>hs623</italic> deletions (5 founders). The distribution of LHX6 consensus motifs in <italic>hs623</italic> are indicated. Founder 2458 was used for the analysis presented in this paper</p></caption><graphic id="MO2" xlink:href="13064_2018_119_Fig2_HTML"></graphic></fig></p>
</sec>
<sec id="Sec16">
<title>Motif logic direct region specific transcriptional activity</title>
<p id="Par77"><italic>Hs623</italic> is flanked by two highly conserved regions and the activity of one of the regions (<italic>hs357)</italic> has been tested in vivo [<xref ref-type="bibr" rid="CR32">32</xref>]. Similar to <italic>hs623, hs357</italic> is active in the spinal cord, but unlike <italic>hs623</italic> it is active in the pretectum and it lacks activity in the telencephalon, including the MGE (Fig. <xref ref-type="fig" rid="Fig2">2f</xref> and <xref ref-type="fig" rid="Fig2">g</xref>). Therefore, despite the close proximity of <italic>hs623</italic> and <italic>hs357</italic>, they show differences in regional activity, suggesting that their regional activities are more likely due to differences in their primary nucleic acid sequence rather then their genomic location. Consistent with the lack of MGE activity, <italic>hs357</italic> has two NKX2–1 consensus motifs and no LHX6 consensus motifs (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). On the other hand, <italic>hs623</italic> has four LHX6 consensus motifs, which could explain its activity in the MGE (Fig. <xref ref-type="fig" rid="Fig2">2h</xref>). Even though <italic>hs623</italic> has NKX2–1 binding, it contains no NKX2–1 consensus motifs. However, the sequences flanking <italic>hs623</italic> do include three NKX2–1 consensus motifs, two within <italic>hs357</italic> (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). In agreement with these observations, we detect NKX2–1 binding covering a wide region that incudes both <italic>hs623</italic> and <italic>hs357</italic>.</p>
</sec>
<sec id="Sec17">
<title>CRISPR/Cas9 mediated deletion of <italic>hs623</italic> in vivo</title>
<p id="Par78">To functionally test the requirement of <italic>hs623</italic> in vivo, we deleted <italic>hs623</italic> using CRISPR/Cas9 (see VISTA database; <ext-link ext-link-type="uri" xlink:href="http://enhancer.lbl.gov">http://enhancer.lbl.gov</ext-link>). A pair of sgRNAs was designed to delete the 734 bp core sequence of <italic>hs623</italic>, which has NKX2–1 and LHX6 binding (Fig. <xref ref-type="fig" rid="Fig2">2b</xref> and <xref ref-type="fig" rid="Fig2">h</xref>). Microinjection of sgRNAs and Cas9 generated a total of 22 pups. 23% (5 of 22) of the pups carried the desired <italic>hs623</italic> deletions and the induced DNA breaks were distributed within 20 bp of the predicted cutting site (5′ and 3′ of <italic>hs623</italic>, Fig. <xref ref-type="fig" rid="Fig2">2h</xref>, Additional file <xref ref-type="media" rid="MOESM3">3</xref>). To minimize potential off target effects we outcrossed the F0 transgenic founders to wild-type CD1 mice. Four of five founders were fertile and generated a F1 generation; these animals were intercrossed to generate homozygous F2 <italic>hs623KO</italic> animals. <italic>Hs623KOs</italic> in the F2 generation were produced at Mendelian Ratios showing that the enhancer deletion was viable (10[WT]:19[HET]:7[KO], <italic>n</italic> = 3 litters; χ<sup>2</sup> = 0.611; df = 2; <italic>p</italic> = 0.7367). Due to the overall similarity of the four fertile founders we decided to focus the following analysis on one of the founders (F0: 2458, Fig. <xref ref-type="fig" rid="Fig2">2h</xref>).</p>
</sec>
<sec id="Sec18">
<title>Deletion of <italic>hs623</italic> reduces <italic>Tcf12</italic> mRNA levels in the SVZ of MGE</title>
<p id="Par79"><italic>Hs623</italic> is a <italic>Tcf12</italic> intragenic RE that in transgenic assays activates transcription in the SVZ of the MGE (Fig. <xref ref-type="fig" rid="Fig2">2c-e</xref>). As noted above, its activity is partly dependent on NKX2–1 activity and <italic>Tcf12</italic> transcription is specifically reduced in the SVZ of the MGE in the <italic>Nkx2–1</italic>cKO (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>) [<xref ref-type="bibr" rid="CR18">18</xref>]. Together, these data suggest that <italic>hs623</italic> could be a RE activating <italic>Tcf12</italic> transcription in the MGE. To test this hypothesis, we performed RTqPCR on the MGE from <italic>hs623WTs</italic> and <italic>hs623KOs</italic> at E13.5. Primers were designed to target all known mouse protein-coding and non-protein-coding genes in the NCBI RNA reference sequences collection that are found 450 kb up- and downstream of <italic>hs623</italic> (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). From the RTqPCR we found no significant difference in the expression of the following genes in this region: <italic>Myzap</italic>, <italic>Cgln1</italic>, <italic>Zfp280d</italic> and <italic>Mns1</italic> (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>). <italic>Tcf12</italic> RNAs include a variety of splice variants. Because of this we designed three separate primer pairs to specifically interrogate the different splice variants of <italic>Tcf12</italic> (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). We found a reduction in the expression of the short isoforms of <italic>Tcf12</italic> isoform 3 and 4 (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>, see <italic>Tcf12</italic>_v1/3–4 and <italic>Tcf12</italic>_v1/3–5). Notably, we did not find any difference in the expression levels of the longer isoforms 1 and 2 of <italic>Tcf12</italic> (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>, see <italic>Tcf12</italic>_v1/2–2). Together, these results show that <italic>Tcf12</italic> transcription in the MGE is enhanced by <italic>hs623</italic>.<fig id="Fig3"><label>Fig. 3</label><caption><p>Reduced <italic>Tcf12</italic> expression in the <italic>hs623</italic>KO. <bold>a</bold>
<italic>Tcf12</italic> locus with neighboring genes. <bold>b</bold> qPCR analysis of <italic>Mns1</italic>, <italic>Myzap</italic>, <italic>Cgln1</italic>, <italic>Zfp280d</italic>, <italic>Tcf12</italic> isoforms 1 and 3 (<italic>Tcf12</italic>_v1/3–4), <italic>Tcf12</italic> isoforms 3 and 4 (<italic>Tcf12</italic>_v1/3–5), <italic>Tcf12</italic> variant 1 and 2 (<italic>Tcf12</italic>_v1/2–2) on WT and <italic>hs623</italic>KO MGE at E13.5. The colors used in the table correlate to the specific target regions indicated in Fig. 3a. <bold>c</bold> and <bold>d</bold> In situ hybridization analysis of <italic>Tcf12</italic> in WT (<bold>c</bold>) and <italic>hs623</italic>KO (<bold>d</bold>) basal ganglia at E13.5. Unpaired t-test was used to test significance between the groups: *<italic>p</italic> &lt; 0.05</p></caption><graphic id="MO3" xlink:href="13064_2018_119_Fig3_HTML"></graphic></fig></p>
<p id="Par80">To obtain spatial information about the reduction of <italic>Tcf12</italic> within the MGE we compared the distribution of <italic>Tcf12</italic> RNA between WT and <italic>hs623KO</italic> telencephalon at E13.5 using in situ RNA hybridization. Normally, <italic>Tcf12</italic> is broadly expressed in the VZ in the pallium and subpallium. In the ganglionic eminences <italic>Tcf12</italic> is also expressed in the SVZ and MZ, with a markedly higher expression in the MGE compared to the LGE. On the other hand, in the <italic>hs623KO</italic> we observed a reduction of <italic>Tcf12</italic> expression that appeared to be specific to the SVZ and MZ of the MGE (Fig. <xref ref-type="fig" rid="Fig3">3c</xref> and <xref ref-type="fig" rid="Fig3">d</xref>). This result is consistent with the spatial activity of <italic>hs623</italic>, which is restricted to the SVZ of the MGE.</p>
</sec>
<sec id="Sec19">
<title>Combined activity of POU and SOX TFs are required to maintain gene expression downstream of NKX2–1 in the MGE</title>
<p id="Par81">To test the functional requirement of the LHX6 motifs in <italic>hs623</italic> we made site directed mutations that removed all four LHX6 motifs (<italic>hs623</italic>ΔLHX). In MGE primary cultures the activity of <italic>hs623</italic>ΔLHX was reduced by half when compared to the non-mutated <italic>hs623</italic> (<italic>hs623</italic>WT, Fig. <xref ref-type="fig" rid="Fig4">4a</xref> and <xref ref-type="fig" rid="Fig4">b</xref>). Together, these experiments provide evidence that <italic>hs623</italic> activity, in part, depends on LHX6 and LHX8 and that there are additional TFs and signaling pathways required for the activity of <italic>hs623</italic>. Our earlier motif analysis of aREs discovered an enrichment of additional motifs such as HD-binding motifs (POU6f2 and HOX), SOX motifs and E-boxes (Fig. <xref ref-type="fig" rid="Fig1">1e</xref>). To identify additional TF pathways responsible for the activity of <italic>hs623</italic> we looked at the other identified de novo motifs within <italic>hs623</italic> (Fig. <xref ref-type="fig" rid="Fig1">1d</xref>). Located in the center of <italic>hs623</italic> we found two octamers (bound by POU TFs), of which one is adjacent to a SOX motif. Octamers are known to pair with SOX motifs to form central functional units regulating development in various cell types [<xref ref-type="bibr" rid="CR33">33</xref>–<xref ref-type="bibr" rid="CR35">35</xref>]. Initially, we analyzed the activity of the two individual octamers by generating single mutations of the two motifs (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>, <italic>hs623</italic>ΔOCT1 and <italic>hs623</italic>ΔOCT2). Mutating octamer 1 (<italic>hs623ΔOCT1</italic>) caused a significant reduction of <italic>hs623</italic> activity in MGE primary cultures, whereas mutating octamer 2 (<italic>hs623ΔOCT2</italic>) had no significant effect on <italic>hs623</italic> activity (Fig. <xref ref-type="fig" rid="Fig4">4b</xref>). Octamer 2 is located 3 bp from a SOX consensus motif (Fig. <xref ref-type="fig" rid="Fig4">4a</xref>). To assess the requirement of this combined motif for <italic>hs623</italic> activity, we generated a compound mutant with a combined mutation of octamer 2 and the paired SOX motif (<italic>hs623</italic>ΔOCT2 + SOX). <italic>Hs623</italic>ΔOCT2 + SOX showed a significantly reduced activity when compared to <italic>hs623</italic>WT as well as, the two individual single mutants, <italic>hs623</italic>ΔOCT2 and <italic>hs623</italic>ΔSOX (Fig. <xref ref-type="fig" rid="Fig4">4b</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>OCT and SOX motifs required for <italic>hs623</italic> activity in primary MGE cultures. <bold>a</bold> Schematic of <italic>hs623</italic> with LHX6, OCT and SOX motifs. <bold>b</bold> Luciferase reporter assay showing a reduced activity of <italic>hs623</italic> when LHX6, OCT and SOX motifs in <italic>hs623</italic> are mutated. Data are represented as mean ± SEM. Unpaired t-test was used to test significance between the groups: *<italic>p</italic> &lt; 0.05, **<italic>p</italic> &lt; 0.01, ***<italic>p</italic> &lt; 0.001, ****<italic>p</italic> &lt; 0.0001</p></caption><graphic id="MO4" xlink:href="13064_2018_119_Fig4_HTML"></graphic></fig></p>
<p id="Par82">Altogether, our experiments show that <italic>Tcf12</italic> expression in the SVZ of the MGE is mediated, at least in part, through <italic>hs623</italic>, a RE that is strongly dependent on its OCT and SOX motifs and partially dependent on its LHX6 motifs. We have previously shown that gene expression in the SVZ of the MGE (including <italic>Tcf12</italic>) largely depends on NKX2–1 activity [<xref ref-type="bibr" rid="CR18">18</xref>]. Existing mechanistic data show that NKX2–1 acts as a transcriptional repressor. Therefore, our findings suggest that the loss of <italic>Tcf12</italic> expression in the SVZ of the MGE <italic>Nkx2–1c</italic>KO is not due to the direct regulation of <italic>Tcf12</italic> by NKX2–1, but is a secondary effect due to changes in expression and activity of LHX6, LHX8, OCT and SOX TFs.</p>
</sec>
</sec>
<sec id="Sec20">
<title>Discussion</title>
<p id="Par83">Technical advancements in genome wide sequencing, chromosome capture and CRISPR/Cas9 technologies are increasing our understanding of genome organization. These data, combined with data showing RE activities in vivo (<ext-link ext-link-type="uri" xlink:href="https://enhancer.lbl.gov/">https://enhancer.lbl.gov/</ext-link>), TF binding and other epigenetic genomic data, and spatial gene expression data (<ext-link ext-link-type="uri" xlink:href="http://www.brain-map.org/">http://www.brain-map.org/</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.eurexpress.org/ee/intro.html">http://www.eurexpress.org/ee/intro.html</ext-link>), are enabling the field to begin elucidating the genomic networks and the molecular mechanisms that direct brain development. Herein we have used many of these approaches to analyze gene expression in the developing mouse MGE. In the context of the <italic>Nkx2–1</italic>cKO mouse, our analysis of differential (WT vs. cKO) histone ChIP-seq data, and de novo sequence motif analysis, has provided evidence for additional TFs, REs, and signaling pathways that direct MGE development.</p>
<p id="Par84">In this study, we showed that <italic>Tcf12</italic> expression in the SVZ of the MGE is mediated via <italic>hs623</italic>, an aRE bound by NKX2–1. The activity of <italic>hs623</italic> and the expression of <italic>Tcf12</italic> depend on NKX2–1 activity, suggesting that NKX2–1 promotes <italic>Tcf12</italic> expression in this context. We find no direct evidence showing that NKX2–1 activates <italic>Tcf12</italic> transcription via <italic>hs623</italic>. On the other hand, we show that LHX6, OCT and SOX motives are central to <italic>hs623</italic> activity. In fact, <italic>hs623</italic> lacks NKX2–1 consensus motifs and its interaction with <italic>hs623</italic> can possibly be explained through binding to three flanking regions. Other alternative explanations are that NKX2–1 regulates <italic>hs623</italic> through either uncharacterized NKX2–1 motifs or through indirect binding to transcriptional complexes that bind <italic>hs623</italic>.</p>
<p id="Par85">We have earlier demonstrated that NKX2–1 represses transcription in the MGE, similar to other NKX HD TFs that specify ventral parts of the developing neural tube [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. Even at aREs, identified in the <italic>Nkx2–1</italic>cKO MGE, the NKX2–1 motifs mediate transcriptional repression, as exemplified by the intragenic <italic>Tgfb3</italic> RE in Sandberg et al. 2016 [<xref ref-type="bibr" rid="CR18">18</xref>]. On the other hand, in the case of both the <italic>Tgfb3</italic> RE and <italic>hs623</italic>, LHX6 motifs promote enhancer activity. If NKX2–1 only represses transcription, it is unclear how loci such as LHX6 and LHX8 fail to be activated in the <italic>Nkx2–1</italic> mutants [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Furthermore it is unclear why NKX2–1 also binds loci that have reduced activity in the <italic>Nkx2–1</italic>cKO. These results suggest that, in some contexts, NKX2–1 may have an activating function. NKX2–1 binding to these loci might be required to keep them poised for subsequent activation by TFs and signaling pathways parallel and genetically downstream of NKX2–1, such as LHX, OCT, SOX and bHLH TFs. A similar model was presented in two studies looking at motor neuron development. In these cells, combinations of NEUROG2 (bHLH TF), LHX3, ISL-1, ONECUT1 and EBF direct the progression of the motor neuron fate through distinct sets of REs [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Similar to these models, we find an enrichment of LHX6 binding and e-boxes at aREs, a group of REs with a preferential activity in the SVZ of the MGE. This combination of TF binding and motif enrichment is not seen at NKX2–1 bound rREs, that have a relatively low MGE activity. These data highlight similarities in the molecular mechanisms that direct MGE and motor neuron development over time. In addition to combinatorial activity with other TFs, the activity of NKX2–1 might be affected by changes to chromatin modifications at specific loci over time. Our experimental design lacks the temporal resolution to make these kinds of predictions. For the future, it would be interesting to know; 1) at what time point in the developing MGE (VZ, SVZ or MZ) are the various REs active, 2) and the temporal pattern of TF binding at these REs. This would give us important information that could help elucidate the activating and repressing mechanics through which NKX2–1, LHX6 and other TFs direct MGE development.</p>
<p id="Par86">The seemingly dual activity of NKX2–1 in the MGE is similar to its double-edged characteristics in regulating cancer development and progression. In this context, NKX2–1 has a role as lineage-survival oncogene in developing lung cancer tumors. On the other hand, NKX2–1 expression is also associated with a favorable prognosis in affected patients, due to its capacity to attenuate the invasive capacity of carcinomas [<xref ref-type="bibr" rid="CR38">38</xref>]. Interestingly, this has been shown to be mediated through an abrogation of cellular response to TGFβ induced EMT, a signaling pathway that is directly repressed by NKX2–1 in the MGE [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. By identifying the mechanisms through which NKX2–1 operate in the subpallial telencephalon we might also learn more about its enigmatic role in tumor biology.</p>
<p id="Par87">The activity of the RE <italic>hs623</italic> depends on two octamers, providing evidence that OCT TFs are central to MGE development. OCT TFs are important regulators of stem cell maintenance and the progression of neurogenesis. OCT4 is central for propagating undifferentiated embryonic stem cells and has the ability to induce pluripotent stem cells from embryonic and adult fibroblasts [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. On the contrary, BRN2, together with Ascl1 and Myt1l, can efficiently trans-differentiate embryonic and postnatal fibroblasts into functional neurons [<xref ref-type="bibr" rid="CR42">42</xref>]. BRN1, BRN2 and OCT6 mutants show defects in layering of the neocortex, due to their role in initiating radial migration of cortical projection neurons, further highlighting their role in promoting neurogenesis [<xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR45">45</xref>]. Furthermore, we find an enrichment of both octamers and E-boxes in REs promoting gene expression in the MGE, suggesting that the TF machinery directing trans-differentiation of fibroblasts into neurons is similar to the TF machinery inducing neuronal phenotypes in the MGE. Trans-differentiating fibroblast to neurons using Brn2, Ascl1 and Myt1l generate cells with a mixed neuronal phenotype [<xref ref-type="bibr" rid="CR42">42</xref>], indicating that these TFs are required for promoting the neuronal fate, without any preference for specific neuronal lineages. Taken together, this suggests a model where neuronal fate and phenotype is directed through separate, although integrated, TF pathways in the MGE.</p>
<p id="Par88">One of the octamers in <italic>hs623</italic> is paired with a SOX motif. The SOX TF family consists of a large number of genes that direct embryonic development and cell differentiation. They bind loosely to the minor groove of the DNA and their target gene specificity is guided through the interaction with cell type specific partner factors such as OCT TFs. The combined activity of SOX2 and different OCT TFs are important regulators of gene expression in undifferentiated embryonic stem cells (ESCs) and neural progenitor cells (NPCs) [<xref ref-type="bibr" rid="CR46">46</xref>]. SOX2 and OCT4 (POU5F1) bind REs in ECSs, whereas SOX2 and BRN2 (POU3F2) co-occupy REs in NPCs [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>]. SOX and OCT motifs have also been shown to direct transcription in both ESCs and NPCs in the forebrain [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Today we do not know what specific OCT and SOX TFs that are required to activate transcription in the SVZ of the MGE, via REs like <italic>hs623</italic>, BRN1 (POU3F3), BRN2 (POU3F2), BRN4 (POU3F4), BRN5 (POU6F1) and OCT6 (POU3F1) are all expressed here, but little is know regarding their function in this context. A large number of different SOX TFs are expressed in the MGE and several of them show a reduced expression in the <italic>Nkx2–1</italic>cKO, such as Sox1, Sox2, Sox6, Sox11 and Sox21 constituting possible candidates for promoting <italic>Tcf12</italic> expression via <italic>hs623</italic>. Sox6 is required for patterning of the subpallium and generation on MGE derived interneurons [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>], but when looking at <italic>Tcf12</italic> expression in the E13.5 MGE of a conditional <italic>Sox6</italic> mouse [<xref ref-type="bibr" rid="CR51">51</xref>] with an <italic>Nkx2–1</italic>-Cre line [<xref ref-type="bibr" rid="CR52">52</xref>], we found no significant change in <italic>Tcf12</italic> expression (Additional file <xref ref-type="media" rid="MOESM4">4</xref>). From this we can suggest that SOX6 is not sufficient for promoting <italic>Tcf12</italic> expression. Further studies should be performed to identify the specific OCT and SOX TFs directing transcriptional activation in the MGE.</p>
<p id="Par89">Here, in our new analysis of the <italic>Nkx2–1c</italic>KO, we found a large number aREs. Some of these are near the loci of the <italic>Tcf4</italic> and <italic>Tcf12</italic> bHLH TF encoding genes. The <italic>Nkx2–1</italic>cKO shows a near complete loss of <italic>Tcf12</italic> expression in the SVZ and MZ of the MGE. We found an aRE intronic to <italic>Tcf12</italic> (<italic>hs623</italic>) that has activity in the SVZ and MZ of the MGE (Fig. <xref ref-type="fig" rid="Fig2">2e</xref>). Deletion of <italic>hs623</italic> leads to a reduced <italic>Tcf12</italic> expression in the VZ and MZ of the MGE. This result suggests that <italic>Tcf12</italic> expression is regulated through several aREs, including <italic>hs623</italic>, and that there is redundancy between these REs. Enhancer redundancy has been demonstrated in the developing telencephalon and limb where REs sharing a similar spatiotemporal activity provides robustness to gene expression [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. We also find that there are different genetic programs directing <italic>Tcf12</italic> expression in various cell types of the MGE. <italic>Tcf12</italic> expression is initiated in the VZ of the MGE; this expression is largely unaffected in the <italic>Nkx2–1</italic>cKO, indicating that <italic>Tcf12</italic> expression in this region is not mediated through <italic>hs623</italic> and largely NKX2–1 independent.</p>
<p id="Par90">Altogether, these data provide evidence of transcriptional circuitry that connects the initiation of MGE fate in the VZ by <italic>Nkx2–1</italic> and <italic>Otx2</italic>, to the maturation of cells in the SVZ and MZ by driven through REs such as <italic>hs632,</italic> whose activity integrates signals from LHX, OCT, SOX and bHLH TFs [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Future studies will investigate how TFs, chromatin-binding, −reading and -remodeling proteins integrate to direct GABAergic and cholinergic development in the subpallial telencephalon.</p>
</sec>
<sec id="Sec21">
<title>Conclusion</title>
<p id="Par91">In our study we use a combination of genomics, CRISPR/Cas9 engineering and TF motif analysis to investigate the transcriptional networks guiding development of the MGE and its descendants. Whereas NKX2–1 is required for initiating MGE characteristics in the VZ, we provide evidence that a combination of LHX, OCT, SOX and bHLH TFs are central for maintaining gene expression in the SVZ and MZ, genetically down-stream of NKX2–1. Here we generate a mouse mutant in whom we delete a <italic>Tcf12</italic> intragenic RE, showing its requirement for maintaining <italic>Tcf12</italic> transcription in the SVZ and MZ of the MGE. The activity of this <italic>Tcf12</italic> enhancer, in primary cultures of MGE cells, largely depends on an octamer and a combined octamer and SOX motif. Altogether, our study identifies a genomic framework through which a combination of LHX, OCT, SOX and bHLH TFs direct MGE differentiation through the expression terminal effector genes.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec22">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="13064_2018_119_MOESM1_ESM.xlsx"><label>Additional file 1:</label><caption><p>aREs and rREs in the Nkx2–1cKO MGE at e13.5<bold>.</bold> Identified activating (sheet “aRE”) and repressing (sheet “rRE”) regulatory elements in Nkx2–1cKO MGE at e13.5. In vivo activity of aREs (sheet “VISTA aRE”) and rREs (sheet “VISTA rRE”) VISTA transgenics at E11.5. (XLSX 696 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="13064_2018_119_MOESM2_ESM.pdf"><label>Additional file 2:</label><caption><p>Forebrain activity of hs623. Coronal sections of the hs623 transgene showing its activity in forebrain at E11.5. The sections are arranged rostral (A) to caudal (S). (PDF 135 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="13064_2018_119_MOESM3_ESM.pdf"><label>Additional file 3:</label><caption><p>DNA sequences of hs623KO founder mice. DNA sequence of the modified <italic>hs623</italic> locus in the five founder mice carrying the hs623 deletion. (PDF 65 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="13064_2018_119_MOESM4_ESM.pdf"><label>Additional file 4:</label><caption><p>Tcf12 expression in Sox6 conditional knockout. In situ analysis of <italic>Tcf12</italic> in WT (A) and <italic>Sox6</italic> conditional knockout (B) forebrain at E13.5. (PDF 4383 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>aREs</term>
<def>
<p id="Par5">activating regulatory element</p>
</def>
</def-item>
<def-item>
<term>bHLH</term>
<def>
<p id="Par6">basic-helix-loop-helix</p>
</def>
</def-item>
<def-item>
<term>cKO</term>
<def>
<p id="Par7">conditional knockout</p>
</def>
</def-item>
<def-item>
<term>E</term>
<def>
<p id="Par8">embryonic day</p>
</def>
</def-item>
<def-item>
<term>GO</term>
<def>
<p id="Par9">gene ontology</p>
</def>
</def-item>
<def-item>
<term>HD</term>
<def>
<p id="Par10">homeodomain</p>
</def>
</def-item>
<def-item>
<term>LGE</term>
<def>
<p id="Par11">lateral ganglionic eminence</p>
</def>
</def-item>
<def-item>
<term>MGE</term>
<def>
<p id="Par12">medial ganglionic eminence</p>
</def>
</def-item>
<def-item>
<term>MZ</term>
<def>
<p id="Par13">mantle zone</p>
</def>
</def-item>
<def-item>
<term>REs</term>
<def>
<p id="Par14">regulatory elements</p>
</def>
</def-item>
<def-item>
<term>rREs</term>
<def>
<p id="Par15">repressing regulatory element</p>
</def>
</def-item>
<def-item>
<term>SVZ</term>
<def>
<p id="Par16">sub-ventricular zone</p>
</def>
</def-item>
<def-item>
<term>TF</term>
<def>
<p id="Par17">transcription factor</p>
</def>
</def-item>
<def-item>
<term>VZ</term>
<def>
<p id="Par18">ventricular zone</p>
</def>
</def-item>
<def-item>
<term>WT</term>
<def>
<p id="Par19">wild-type</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>We thank members of the Rubenstein, Taher, Black and Nord laboratories for advice and critical evaluation of the data during the course of the study.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par92">This project was supported by Vetenskapsrådet 2011–38865–83000-30 (M.S.), Svenska Sällskapet för Medicinsk Forskning (M.S.), NIMH R01 MH081880 (J.L.R.R.), NIH R01s HL064658 (B.L.B.) and HL136182 (B.L.B.)</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par93">The datasets supporting the conclusions of this article are available in the NCBI’s GEO repository, GEO Series accession number GSE85705 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85705">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85705</ext-link> acc.cgi?acc = GSE85705). Additional material is available from the corresponding author upon request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>MS, JLRR and AN conceived the experiments, interpreted the results, wrote, reviewed and edited the manuscript. MS designed and performed all experiments. JH and BB injected sgRNA and Cas9 to generate <italic>hs623</italic>KO mice. LT performed the differential ChIP-seq enrichment analysis. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p>All animal procedures were performed following protocols (AN143392-02B [J.L.R.R.] and AN171299–01 [B.L.B.]) authorized by the University of California San Francisco Institutional Animal Care and Use Committee (IACUC).</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>J.L.R.R. is cofounder, stockholder, and currently on the scientific board of <italic>Neurona</italic>, a company studying the potential therapeutic use of interneuron transplantation.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nord</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Pattabiraman</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Visel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
</person-group>
<article-title>Genomic perspectives of transcriptional regulation in forebrain development</article-title>
<source/>Neuron Elsevier Inc
          <year>2015</year>
<volume>85</volume>
<fpage>27</fpage>
<lpage>47</lpage>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<mixed-citation publication-type="other">De Rubeis S, He X, Goldberg AP, Poultney CS, Samocha K, Ercument Cicek A, et al. Synaptic, transcriptional and chromatin genes disrupted in autism. 2014.</mixed-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pennacchio</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Ahituv</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Moses</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Prabhakar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nobrega</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Shoukry</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>In vivo enhancer analysis of human conserved non-coding sequences</article-title>
<source/>Nature. Nature Publishing Group
          <year>2006</year>
<volume>444</volume>
<fpage>499</fpage>
<lpage>502</lpage>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Blow</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Akiyama</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Holt</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>ChIP-seq accurately predicts tissue-specific activity of enhancers</article-title>
<source/>Nat Publ Group
          <year>2009</year>
<volume>457</volume>
<fpage>854</fpage>
<lpage>858</lpage>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zinzen</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Girardot</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gagneur</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Braun</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Furlong</surname>
<given-names>EEM</given-names>
</name>
</person-group>
<article-title>Combinatorial binding predicts spatio-temporal cis-regulatory activity</article-title>
<source/>Nat Publ Group
          <year>2009</year>
<volume>462</volume>
<fpage>65</fpage>
<lpage>70</lpage>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonev</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Fritsch</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Papadopoulos</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Lubling</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiscale 3D Genome Rewiring during Mouse Neural Development</article-title>
<source/>Cell. Elsevier
          <year>2017</year>
<volume>171</volume>
<fpage>557</fpage>
<lpage>572.e24</lpage>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Taher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Girgis</surname>
<given-names>H</given-names>
</name>
<name>
<surname>May</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Golonzhka</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hoch</surname>
<given-names>RV</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A high-resolution enhancer atlas of the developing telencephalon</article-title>
<source/>Cell
          <year>2013</year>
<volume>152</volume>
<fpage>895</fpage>
<lpage>908</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2012.12.041</pub-id>
<pub-id pub-id-type="pmid">23375746</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rhee</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Closser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bashkirova</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Gifford</surname>
<given-names>DK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expression of terminal effector genes in mammalian neurons is maintained by a dynamic relay of transient enhancers</article-title>
<source/>Neuron. Elsevier
          <year>2016</year>
<volume>92</volume>
<fpage>1252</fpage>
<lpage>1265</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.11.037</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velasco</surname>
<given-names>Silvia</given-names>
</name>
<name>
<surname>Ibrahim</surname>
<given-names>Mahmoud M.</given-names>
</name>
<name>
<surname>Kakumanu</surname>
<given-names>Akshay</given-names>
</name>
<name>
<surname>Garipler</surname>
<given-names>Görkem</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>Begüm</given-names>
</name>
<name>
<surname>Al-Sayegh</surname>
<given-names>Mohamed Ahmed</given-names>
</name>
<name>
<surname>Hirsekorn</surname>
<given-names>Antje</given-names>
</name>
<name>
<surname>Abdul-Rahman</surname>
<given-names>Farah</given-names>
</name>
<name>
<surname>Satija</surname>
<given-names>Rahul</given-names>
</name>
<name>
<surname>Ohler</surname>
<given-names>Uwe</given-names>
</name>
<name>
<surname>Mahony</surname>
<given-names>Shaun</given-names>
</name>
<name>
<surname>Mazzoni</surname>
<given-names>Esteban O.</given-names>
</name>
</person-group>
<article-title>A Multi-step Transcriptional and Chromatin State Cascade Underlies Motor Neuron Programming from Embryonic Stem Cells</article-title>
<source/>Cell Stem Cell
          <year>2017</year>
<volume>20</volume>
<issue>2</issue>
<fpage>205-217.e8</fpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2016.11.006</pub-id>
<pub-id pub-id-type="pmid">27939218</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lupiáñez</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Kraft</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Heinrich</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Krawitz</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Brancati</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Klopocki</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruptions of topological chromatin domains cause pathogenic rewiring of gene-enhancer interactions</article-title>
<source/>Cell
          <year>2015</year>
<volume>161</volume>
<fpage>1012</fpage>
<lpage>1025</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.04.004</pub-id>
<pub-id pub-id-type="pmid">25959774</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Dorsal-ventral patterning in the mammalian telencephalon</article-title>
<source/>Curr Opin Neurobiol
          <year>2003</year>
<volume>13</volume>
<fpage>50</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="doi">10.1016/S0959-4388(03)00009-6</pub-id>
<pub-id pub-id-type="pmid">12593982</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<mixed-citation publication-type="other">Rubenstein JLR, Campbell K. Neurogenesis in the Basal Ganglia. Patterning and Cell Type Specification in the Developing CNS and PNS. Elsevier. 2013:455–73.</mixed-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Marin</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hermesz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Flames</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Palkovits</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The LIM-homeobox gene Lhx8 is required for the development of many cholinergic neurons in the mouse forebrain</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>100</volume>
<fpage>9005</fpage>
<lpage>9010</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1537759100</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fragkouli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Wijk</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kessaris</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Pachnis</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>LIM homeodomain transcription factor-dependent specification of bipotential MGE progenitors into cholinergic and GABAergic striatal interneurons</article-title>
<source/>Development
          <year>2009</year>
<volume>136</volume>
<fpage>3841</fpage>
<lpage>3851</lpage>
<pub-id pub-id-type="doi">10.1242/dev.038083</pub-id>
<pub-id pub-id-type="pmid">19855026</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ocbina</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>S. A.</given-names>
</name>
</person-group>
<article-title>NKX2.1 specifies cortical interneuron fate by activating Lhx6</article-title>
<source/>Development
          <year>2008</year>
<volume>135</volume>
<issue>8</issue>
<fpage>1559</fpage>
<lpage>1567</lpage>
<pub-id pub-id-type="doi">10.1242/dev.015123</pub-id>
<pub-id pub-id-type="pmid">18339674</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<mixed-citation publication-type="other">Sussel L, Marin O, Kimura S, Rubenstein JL. Loss of Nkx2.1 homeobox gene function results in a ventral to dorsal molecular respecification within the basal telencephalon: evidence for a transformation of the pallidum into the striatum. Development. 1999;</mixed-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Butt</surname>
<given-names>SJB</given-names>
</name>
<name>
<surname>Sousa</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Fuccillo</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>Hjerling-Leffler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Miyoshi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes</article-title>
<source/>Neuron
          <year>2008</year>
<volume>59</volume>
<fpage>722</fpage>
<lpage>732</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2008.07.031</pub-id>
<pub-id pub-id-type="pmid">18786356</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sandberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Flandin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Silberberg</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Su-Feher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>JS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptional networks controlled by NKX2-1 in the development of forebrain GABAergic neurons</article-title>
<source/>Neuron
          <year>2016</year>
<volume>91</volume>
<fpage>1260</fpage>
<lpage>1275</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.08.020</pub-id>
<pub-id pub-id-type="pmid">27657450</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogt</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Mandal</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sandberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Silberberg</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Nagasawa</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Lhx6 directly regulates Arx and CXCR7 to determine cortical interneuron fate and laminar position</article-title>
<source/>Neuron
          <year>2014</year>
<volume>82</volume>
<fpage>350</fpage>
<lpage>364</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.02.030</pub-id>
<pub-id pub-id-type="pmid">24742460</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kusakabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hoshi</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hoshi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid</article-title>
<source/>Mol Endocrinol
          <year>2006</year>
<volume>20</volume>
<fpage>1796</fpage>
<lpage>1809</lpage>
<pub-id pub-id-type="doi">10.1210/me.2005-0327</pub-id>
<pub-id pub-id-type="pmid">16601074</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schüller</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Heine</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kho</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Dillon</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y-G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acquisition of Granule Neuron Precursor Identity is a critical determinant of progenitor cell competence to form Shh-induced Medulloblastoma</article-title>
<source/>Cancer Cell
          <year>2008</year>
<volume>14</volume>
<fpage>123</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccr.2008.07.005</pub-id>
<pub-id pub-id-type="pmid">18691547</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madisen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zwingman</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Sunkin</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Zariwala</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title>
<source/>Nat Neurosci Nature Publishing Group
          <year>2010</year>
<volume>13</volume>
<fpage>133</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2467</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Shivalila</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Dawlaty</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<etal></etal>
</person-group>
<article-title>One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering</article-title>
<source/>Cell
          <year>2013</year>
<volume>153</volume>
<fpage>910</fpage>
<lpage>918</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.04.025</pub-id>
<pub-id pub-id-type="pmid">23643243</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Val</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Heidt</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Khiem</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>S-M</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>BL</given-names>
</name>
</person-group>
<article-title>Mef2c is activated directly by Ets transcription factors through an evolutionarily conserved endothelial cell-specific enhancer</article-title>
<source/>Dev Biol
          <year>2004</year>
<volume>275</volume>
<fpage>424</fpage>
<lpage>434</lpage>
<pub-id pub-id-type="doi">10.1016/j.ydbio.2004.08.016</pub-id>
<pub-id pub-id-type="pmid">15501228</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Flandin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Cuesta</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Westphal</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
</person-group>
<article-title>Distinct molecular pathways for development of telencephalic interneuron subtypes revealed through analysis of Lhx6 mutants</article-title>
<source/>J Comp Neurol
          <year>2008</year>
<volume>510</volume>
<fpage>79</fpage>
<lpage>99</lpage>
<pub-id pub-id-type="doi">10.1002/cne.21772</pub-id>
<pub-id pub-id-type="pmid">18613121</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schaeren-Wiemers</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Gerfin-Moser</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: in situ hybridization using digoxigenin-labelled cRNA probes</article-title>
<source/>Histochemistry Springer-Verlag
          <year>1993</year>
<volume>100</volume>
<fpage>431</fpage>
<lpage>440</lpage>
<pub-id pub-id-type="doi">10.1007/BF00267823</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmittgen</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Livak</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Analyzing real-time PCR data by the comparative CT method</article-title>
<source/>Nat Protoc
          <year>2008</year>
<volume>3</volume>
<fpage>1101</fpage>
<lpage>1108</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2008.73</pub-id>
<pub-id pub-id-type="pmid">18546601</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Livak</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Schmittgen</surname>
<given-names>TD</given-names>
</name>
</person-group>
<article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method</article-title>
<source/>Methods Academic Press
          <year>2001</year>
<volume>25</volume>
<fpage>402</fpage>
<lpage>408</lpage>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas-Chollier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Darbo</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Defrance</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Thieffry</surname>
<given-names>D</given-names>
</name>
<name>
<surname>van Helden</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifs</article-title>
<source/>Nat Protoc
          <year>2012</year>
<volume>7</volume>
<fpage>1551</fpage>
<lpage>1568</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2012.088</pub-id>
<pub-id pub-id-type="pmid">22836136</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silberberg</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Taher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lindtner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sandberg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nord</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Vogt</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Subpallial enhancer transgenic lines: a data and tool resource to study transcriptional regulation of GABAergic cell fate</article-title>
<source/>Neuron Elsevier
          <year>2016</year>
<volume>92</volume>
<fpage>59</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.027</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLean</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Bristor</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hiller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Schaar</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>CB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>GREAT improves functional interpretation of cis-regulatory regions</article-title>
<source/>Nat Biotechnol
          <year>2010</year>
<volume>28</volume>
<fpage>495</fpage>
<lpage>501</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.1630</pub-id>
<pub-id pub-id-type="pmid">20436461</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Visel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Minovitsky</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dubchak</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pennacchio</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>VISTA enhancer browser--a database of tissue-specific human enhancers</article-title>
<source/>Nucleic Acids Res
          <year>2007</year>
<volume>35</volume>
<fpage>D88</fpage>
<lpage>D92</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkl822</pub-id>
<pub-id pub-id-type="pmid">17130149</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamachi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Uchikawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kondoh</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>Pairing SOX off: with partners in the regulation of embryonic development</article-title>
<source/>Trends Genet
          <year>2000</year>
<volume>16</volume>
<fpage>182</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1016/S0168-9525(99)01955-1</pub-id>
<pub-id pub-id-type="pmid">10729834</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Josephson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pickel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Okabe</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Reynolds</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>PA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>POU transcription factors control expression of CNS stem cell-specific genes</article-title>
<source/>Development
          <year>1998</year>
<volume>125</volume>
<fpage>3087</fpage>
<lpage>3100</lpage>
<pub-id pub-id-type="pmid">9671582</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bery</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martynoga</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Guillemot</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Joly</surname>
<given-names>J-S</given-names>
</name>
<name>
<surname>Rétaux</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Characterization of enhancers active in the mouse embryonic cerebral cortex suggests sox/Pou cis-regulatory logics and heterogeneity of cortical progenitors</article-title>
<source/>Cereb Cortex Oxford University Press
          <year>2014</year>
<volume>24</volume>
<fpage>2822</fpage>
<lpage>2834</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bht126</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Briscoe</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pierani</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jessell</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Ericson</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A homeodomain protein code specifies progenitor cell identity and neuronal fate in the ventral neural tube</article-title>
<source/>Cell
          <year>2000</year>
<volume>101</volume>
<fpage>435</fpage>
<lpage>445</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(00)80853-3</pub-id>
<pub-id pub-id-type="pmid">10830170</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muhr</surname>
<given-names>Jonas</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>Elisabet</given-names>
</name>
<name>
<surname>Persson</surname>
<given-names>Madelen</given-names>
</name>
<name>
<surname>Jessell</surname>
<given-names>Thomas M.</given-names>
</name>
<name>
<surname>Ericson</surname>
<given-names>Johan</given-names>
</name>
</person-group>
<article-title>Groucho-Mediated Transcriptional Repression Establishes Progenitor Cell Pattern and Neuronal Fate in the Ventral Neural Tube</article-title>
<source/>Cell
          <year>2001</year>
<volume>104</volume>
<issue>6</issue>
<fpage>861</fpage>
<lpage>873</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(01)00283-5</pub-id>
<pub-id pub-id-type="pmid">11290324</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamaguchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hosono</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yanagisawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>NKX2-1/TTF-1: an enigmatic oncogene that functions as a double-edged sword for Cancer cell survival and progression</article-title>
<source/>Cancer Cell Elsevier
          <year>2013</year>
<volume>23</volume>
<fpage>718</fpage>
<lpage>723</lpage>
<pub-id pub-id-type="doi">10.1016/j.ccr.2013.04.002</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saito</surname>
<given-names>R-A</given-names>
</name>
<name>
<surname>Watabe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Horiguchi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kohyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Saitoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nagase</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Thyroid Transcription Factor-1 Inhibits Transforming Growth Factor-β–Mediated Epithelial-to-Mesenchymal Transition in Lung Adenocarcinoma Cells</article-title>
<source/>Cancer Res. Am Assoc Cancer Res
          <year>2009</year>
<volume>69</volume>
<fpage>2783</fpage>
<lpage>2791</lpage>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyer</surname>
<given-names>Laurie A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>Tong Ihn</given-names>
</name>
<name>
<surname>Cole</surname>
<given-names>Megan F.</given-names>
</name>
<name>
<surname>Johnstone</surname>
<given-names>Sarah E.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>Stuart S.</given-names>
</name>
<name>
<surname>Zucker</surname>
<given-names>Jacob P.</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>Matthew G.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>Roshan M.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>Heather L.</given-names>
</name>
<name>
<surname>Jenner</surname>
<given-names>Richard G.</given-names>
</name>
<name>
<surname>Gifford</surname>
<given-names>David K.</given-names>
</name>
<name>
<surname>Melton</surname>
<given-names>Douglas A.</given-names>
</name>
<name>
<surname>Jaenisch</surname>
<given-names>Rudolf</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>Richard A.</given-names>
</name>
</person-group>
<article-title>Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells</article-title>
<source/>Cell
          <year>2005</year>
<volume>122</volume>
<issue>6</issue>
<fpage>947</fpage>
<lpage>956</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2005.08.020</pub-id>
<pub-id pub-id-type="pmid">16153702</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors</article-title>
<source/>Cell
          <year>2006</year>
<volume>126</volume>
<fpage>663</fpage>
<lpage>676</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.07.024</pub-id>
<pub-id pub-id-type="pmid">16904174</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vierbuchen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ostermeier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>ZP</given-names>
</name>
<name>
<surname>Kokubu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Südhof</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Wernig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Direct conversion of fibroblasts to functional neurons by defined factors</article-title>
<source/>Nature
          <year>2010</year>
<volume>463</volume>
<fpage>1035</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="doi">10.1038/nature08797</pub-id>
<pub-id pub-id-type="pmid">20107439</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McEvilly</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>de Diaz</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Schonemann</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Hooshmand</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Transcriptional regulation of cortical neuron migration by POU domain factors</article-title>
<source/>Science
          <year>2002</year>
<volume>295</volume>
<fpage>1528</fpage>
<lpage>1532</lpage>
<pub-id pub-id-type="doi">10.1126/science.1067132</pub-id>
<pub-id pub-id-type="pmid">11859196</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugitani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakai</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Minowa</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Nishi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jishage</surname>
<given-names>K-I</given-names>
</name>
<name>
<surname>Kawano</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brn-1 and Brn-2 share crucial roles in the production and positioning of mouse neocortical neurons</article-title>
<source/>Genes &amp; Development Cold Spring Harbor Lab
          <year>2002</year>
<volume>16</volume>
<fpage>1760</fpage>
<lpage>1765</lpage>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominguez</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Ayoub</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Rakic</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>POU-III transcription factors (Brn1, Brn2, and Oct6) influence neurogenesis, molecular identity, and migratory destination of upper-layer cells of the cerebral cortex</article-title>
<source/>Cereb Cortex Oxford University Press
          <year>2013</year>
<volume>23</volume>
<fpage>2632</fpage>
<lpage>2643</lpage>
<pub-id pub-id-type="doi">10.1093/cercor/bhs252</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<mixed-citation publication-type="other">Lodato MA, Ng CW, Wamstad JA, Cheng AW, Thai KK, Fraenkel E, et al. SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state. Barsh GS, editor. PLoS Genet. Public Libr Sci; 2013;9:e1003288.</mixed-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambrosetti</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Basilico</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dailey</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites</article-title>
<source/>Mol Cell Biol. Am Soc Microbiol
          <year>1997</year>
<volume>17</volume>
<fpage>6321</fpage>
<lpage>6329</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.17.11.6321</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fukushima</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Okuda</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Muramatsu</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The gene for the embryonic stem cell coactivator UTF1 carries a regulatory element which selectively interacts with a complex composed of Oct-3/4 and Sox-2</article-title>
<source/>Mol Cell Biol . Am Soc Microbiol (ASM)
          <year>1999</year>
<volume>19</volume>
<fpage>5453</fpage>
<lpage>5465</lpage>
<pub-id pub-id-type="doi">10.1128/MCB.19.8.5453</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Azim</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Jabaudon</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fame</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Macklis</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development</article-title>
<source/>Nat Neurosci NIH Public Access
          <year>2009</year>
<volume>12</volume>
<fpage>1238</fpage>
<lpage>1247</lpage>
<pub-id pub-id-type="doi">10.1038/nn.2387</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista-Brito</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hjerling-Leffler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Denaxa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wegner</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The cell-intrinsic requirement of Sox6 for cortical interneuron development</article-title>
<source/>Neuron
          <year>2009</year>
<volume>63</volume>
<fpage>466</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2009.08.005</pub-id>
<pub-id pub-id-type="pmid">19709629</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dumitriu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dy</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Smits</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Generation of mice harboring aSox6 conditional null allele</article-title>
<source/>Genesis
          <year>2006</year>
<volume>44</volume>
<fpage>219</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="doi">10.1002/dvg.20210</pub-id>
<pub-id pub-id-type="pmid">16652367</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Tam</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Fate mapping Nkx2.1-lineage cells in the mouse telencephalon</article-title>
<source/>J Comp Neurol
          <year>2008</year>
<volume>506</volume>
<fpage>16</fpage>
<lpage>29</lpage>
<pub-id pub-id-type="doi">10.1002/cne.21529</pub-id>
<pub-id pub-id-type="pmid">17990269</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osterwalder</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barozzi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Tissières</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Fukuda-Yuzawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mannion</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Afzal</surname>
<given-names>SY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Enhancer redundancy provides phenotypic robustness in mammalian development</article-title>
<source/>Nature. Nat Publ Group
          <year>2018</year>
<volume>489</volume>
<fpage>57</fpage>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickel</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Ypsilanti</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Pla</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Barozzi</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mannion</surname>
<given-names>BJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ultraconserved Enhancers Are Required for Normal Development</article-title>
<source/>Cell
          <year>2018</year>
<volume>172</volume>
<fpage>491</fpage>
<lpage>499.e15</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2017.12.017</pub-id>
<pub-id pub-id-type="pmid">29358049</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoch</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Lindtner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Price</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Rubenstein</surname>
<given-names>JLR</given-names>
</name>
</person-group>
<article-title>OTX2 transcription factor controls regional patterning within the medial ganglionic eminence and regional identity of the septum</article-title>
<source/>Cell Rep
          <year>2015</year>
<volume>12</volume>
<fpage>482</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.1016/j.celrep.2015.06.043</pub-id>
<pub-id pub-id-type="pmid">26166575</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>